Plant-Based Nano-Delivery Systems in the Treatment of Inflammatory Disorders

Area of Science:

• Pharmacology and Nanomedicine
• Natural Product Chemistry
• Immunology

Background:

• Inflammation is a key factor in chronic diseases like cardiovascular and autoimmune conditions, posing significant public health challenges.
• Conventional anti-inflammatory drugs have limitations, including side effects and poor target specificity.
• Medicinal plants and their compounds show promise for anti-inflammatory therapy but suffer from poor bioavailability due to low solubility and rapid metabolism.

Purpose of the Study:

• To review scientific evidence on using medicinal plants and their bioactive compounds encapsulated in nanosystems for inflammatory disorders.
• To integrate in vitro and in vivo studies detailing mechanisms of action and nanodelivery systems.
• To highlight the potential of nanomedicine in overcoming the biopharmaceutical challenges of plant-derived anti-inflammatory agents.

Main Methods:

• Comprehensive literature review of in vitro and in vivo studies.
• Analysis of various medicinal plants and their bioactive phytochemical compounds.
• Examination of different nanosystems used for drug delivery of these compounds.

Main Results:

• Nanosystems significantly improve the characteristics of plant-derived anti-inflammatory compounds.
• Advantages include sustained release, protection from degradation, enhanced tissue specificity, and reduced toxicity.
• Incorporation into nanosystems leads to more favorable therapeutic outcomes for inflammatory conditions.

Conclusions:

• Medicinal plant-derived compounds delivered via nanosystems represent a promising therapeutic strategy for inflammatory disorders.
• Further research is needed for deeper mechanistic understanding and development of targeted, stimuli-responsive, and clinically translatable nanotherapies.
• Advancements in sustainable and cost-effective plant-based nanotherapies are crucial for future clinical application.